Russian Vaccine 'Sputnik-5' Developers Recommend 'AstraZeneca', Combine Both Vaccines in Next Trial
Trials are underway worldwide on the Corona vaccine. In the different parts of the world, the race to make vaccines is first among countries. Meanwhile, Russia has claimed that the vaccine produced by Sputnik-5 is effective on the corona and has called it the world's first corona vaccine. But in other places, there is continuous work on the vaccine. AstraZeneca is also constantly working on its vaccines. Developers of Russia's Corona Vaccine Stupnik said on Thursday that AstraZeneca should try and use a Russian vaccine shot to increase its efficiency.
Russia said that its vaccine Sputnik-5 is 92% effective at protecting people from the corona virus, while Estrjonica said that its testing showed that its vaccine was up to 70 percent effective against Kovid-19 and further 90 percent on the corona. Can be effective up to. Russian vaccine developers said through their Twitter account, "If they go for a new clinical trial, we suggest them to streamline an effort combining shot with #SputnikV human adenoviral vector."
"Combination of vaccines may prove important for vaccination."
AstraZeneca has stated that by the end of 2020 it will have a total of 200 million doses of the vaccine. The British developed vaccine is seen as the best hope for many developing countries because of its affordable price and its ability to be carried at normal refrigerator temperatures. There are 2,187,990 cases of corona virus in Russia, which is the highest after America, India and Brazil. That is, Russia ranks fourth in the world in terms of Corona cases.
AstraZeneca's chief executive, Pascal Soriot, told Bloomberg News that AstraZeneca could run an additional global trial to assess the efficacy of its vaccine. The British government's chief scientific adviser Patrick Valence said that the main thing about the AstraZeneca vaccine was that it worked on the doubts that arose. "The headline result is that the vaccine works and it is very exciting," Valence said during a news briefing with British Prime Minister Boris Johnson.